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Abstract The Ca2 and membrane binding protein annexin 2
can form a heterotetrameric complex with the S100A10 protein
and this complex is thought to serve a bridging or scaffolding
function in the membrane underlying cytoskeleton. To elucidate
which of the subunits targets the complex to the subplasmalem-
mal region in live cells we employed YFP/CFP fusion proteins
and live cell imaging in HepG2 cells. We show that monomeric
annexin 2 is targeted to the plasma membrane whereas non-
complexed S100A10 acquires a general cytosolic distribution.
Co-expression of S100A10 together with annexin 2 and the
resulting complex formation, however, lead to a recruitment of
S100A10 to the plasma membrane thus identifying annexin 2 as
the membrane targeting subunit. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Annexins are a family of cytosolic Ca2 binding proteins
that interact with cellular membranes in a regulated and re-
versible manner. They have been implicated in a variety of
membrane related events ranging from the stabilization of
membrane structures to endocytic and exocytotic membrane
tra⁄c (for review see [1,2]). Central to the annexin action is
their Ca2 dependent binding to negatively charged phospho-
lipids enriched in the cytosolic lea£et of cellular membranes.
This property is contained in a conserved membrane binding
module, the annexin core domain, which is built of four or
eight tandemly repeated homology segments. The second prin-
cipal building block of an annexin is the N-terminal domain
which is unique in sequence and length. Though not being
capable of mediating membrane binding themselves the
N-terminal domains of di¡erent annexins have been shown
to modulate the Ca2 dependent membrane binding displayed
by the annexin cores. Moreover N-terminal annexin sequences
contain binding sites for speci¢c protein ligands which can
also a¡ect canonical annexin properties. A number of such
ligands has been identi¢ed using in vitro approaches, e.g. af-
¢nity chromatography on immobilized annexins, but the exis-
tence and functional signi¢cance of annexin^ligand complexes
within cells has so far remained largely elusive (for review see
[1,2]). The main exception is the complex formed between
annexin 2 and the S100 protein S100A10 (p11). Annexin
2^S100A10 complexes can be isolated from cells and tissues
and the two subunits of the complex often show overlapping
intracellular distributions [3^5].
Complex formation between annexin 2 and S100A10 is
mediated primarily through hydrophobic contacts. These in-
volve aliphatic and aromatic amino acid residues located on
one side of an amphiphatic K-helix comprising the N-terminal
14 residues of annexin 2 and a hydrophobic pocket formed by
a S100A10 dimer [6^9]. When compared to monomeric annex-
in 2 the complex has a reduced Ca2 requirement for binding
to acidic phospholipids and is also capable of aggregating
secretory granules at micromolar Ca2 concentrations
[10,11]. This latter activity is most likely due to the annexin
2^S100A10 complex forming symmetric cross-bridges between
adjacent bilayers with two annexin 2 cores bound to two
separate membranes and linked via a S100A10 dimer. Support
for this view is severalfold. First, quick-freeze, deep-etch elec-
tron microscopy analysis of chroma⁄n and anterior pituitary
secretory cells identi¢ed strands connecting secretory granule
and plasma membrane which are likely to contain annexin
2^S100A10 [12,13]. Second, high resolution cryo-electron mi-
croscopic analysis of junctions formed by annexin 2^S100A10
between arti¢cial liposomes or chroma⁄n granules revealed
highly symmetric structures ¢tting in size with an annexin
2^S100A10 heterotetramer spanning the distance between
two membrane surfaces [14]. Third, crystal structure analysis
of the S100A10 dimer in a complex with a peptide covering
the N-terminal annexin 2 sequence showed that two peptides
reside on opposite sides of the S100A10 dimer which therefore
could serve as a central unit connecting two membrane bind-
ing annexin 2 cores [9].
Within cells the annexin 2^S100A10 complex is located on
both endosomal membranes and the plasma membrane and it
is thought that the subplasmalemmal localization is required
for a functioning of the complex in Ca2 regulated exocytosis
[12,13,15,16]. The Ca2 dependent membrane binding of the
annexin 2 core could mediate a direct interaction of the an-
nexin 2^S100A10 complex with the plasma membrane
although other modes of linking the complex to the submem-
branous region have been proposed. These include a tight
association with the cortical cytoskeleton, possibly mediated
through a binding of annexin 2 to F-actin or spectrin-like
molecules [17] or an association with cholesterol-rich mem-
brane domains [18,19]. Moreover it appears that in adrenergic
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chroma⁄n cells a submembranously anchored S100A10 sub-
unit participates in recruiting cytosolic annexin 2 to the cell
cortex when cells are stimulated to secrete [15]. Such submem-
branous localization of non-complexed S100A10, however, is
not observed in F9 mouse teratocarcinoma cells. In these cells
which do not express annexin 2, S100A10 seems to be a cy-
tosolic, non-membrane-bound protein [20].
To address this apparent controversy and to analyze the
distribution of the subunits of the annexin 2^S100A10 com-
plex in live cells we chose to record the distribution of £uo-
rescent annexin 2 and S100A10 fusion proteins in HepG2
cells. These cells were selected because they express no or
very little endogenous annexin 2 and S100A10 [21] thereby
enabling us to speci¢cally and separately analyze the ectopi-
cally expressed subunits of the complex. We show that annex-
in 2-cyan £uorescent protein (CFP) but not yellow £uorescent
protein (YFP)-S100A10 assumes a plasma membrane local-
ization in singly transfected HepG2 cells. When both fusion
proteins are co-expressed they form complexes and are both
localized to the plasma membrane indicating that the annexin
2 subunit is primarily responsible for anchoring the complex
in the submembranous region.
2. Materials and methods
2.1. Expression constructs
Enhanced YFP, a bright yellow variant of GFP, was attached to
the N-terminus of human S100A10 by cloning full-length S100A10
cDNA into the appropriately linearized pEYFP-C1 vector (Clontech,
Heidelberg, Germany). Enhanced CFP, a bright cyan variant of GFP,
was attached to the C-terminus of human annexin 2 by cloning an-
nexin 2 cDNA into the appropriately linearized pECFP-N1 vector
(Clontech, Heidelberg, Germany). To allow expression of a fusion
protein the stop codon of the annexin cDNA was deleted. Moreover
the cDNA used contained an A65E mutation installing the epitope for
the H28 monoclonal anti-annexin 2 antibody [22] which was used for
immunoprecipitation. Following cloning plasmids were ampli¢ed in
Escherichia coli Top 10 FP (Clontech, Heidelberg, Germany) and pu-
ri¢ed using the Jetstar 2.0 Plasmid kit (Genomed, Bad Oyenhausen,
Germany).
2.2. Cell culture and transfections
HepG2 cells were maintained in RPMI medium with 10% fetal calf
serum, glutamine and antibiotics in a 5% CO2 incubator at 37‡C. For
transient transfections, cells were either grown on cover slips in 35 mm
dishes or in 100 mm dishes and then transfected with E¡ectene (Qia-
gen, Hilden, Germany). 24 h after transfection cells were processed for
£uorescence microscopy or immunoprecipitation.
2.3. Antibodies and immunoblotting
The mouse monoclonal antibody H28 directed against annexin 2
and the monoclonal antibody H21 directed against S100A10 have
been described previously [5]. Living Colors1 A.v. Peptide antibody
was purchased from Clontech (Heidelberg, Germany). Immunoblot-
ting employed PVDF membrane (Millipore, Germany) and HRP-la-
belled secondary antibodies (Dako A/S, Denmark) which were visu-
alized by ECL (Amersham, Germany).
2.4. Fluorescence microscopy
Living cells grown on cover slips were mounted in mowiol with 4%
n-propyl-gallate as antifade agent and then inspected using a DM
RXA £uorescence microscope (Leica, Wetzlar, Germany).
2.5. Immunoprecipitation
Cells were rinsed once with PBS and then lysed with IP-bu¡er
(20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Triton
X-100) containing a cocktail of protease inhibitors (1 mM PMSF,
4 Wg/ml aprotinin, 0.5 Wg/ml leupeptin, 1 Wg/ml pepstatin, 0.5 Wg/ml
TPCK, 20 WM E64). During lysis dishes were maintained at constant
agitation for 30 min on ice. Cells were then scraped from the dish with
a rubber policeman and passed several times through a 22 gauge
needle. The lysate was centrifuged for 10 min at 10 000Ug at 4‡C
and the supernatant was incubated in a pre-clearing step for 2 h at
4‡C with Dynabeads M-450 (sheep anti-mouse IgG). The remaining
non-bound lysate was then incubated over night at 4‡C with Dyna-
beads coated with the respective monoclonal antibodies. Beads were
washed three times with PBS containing 0.05% Triton X-100. Subse-
quently, adsorbed proteins were released by boiling in SDS^sample
bu¡er and analyzed by immunoblotting.
3. Results and discussion
3.1. Annexin 2 and S100A10 assume di¡erent localizations
when expressed individually in HepG2 cells
Previous Western blot analyses had revealed that hepato-
blastoma HepG2 cells express no S100A10 and no or very
little annexin 2 protein [21]. Hence, this cell line appeared to
be a feasible model for studying the intracellular fate of ec-
topically expressed annexin 2 and S100A10 in the absence of
the endogenous proteins. Annexin 2 and S100A10 were ex-
pressed as £uorescent protein chimeras to record their distri-
bution in live cells. CFP and YFP were chosen to allow a
simultaneous detection of both proteins in co-transfected cells.
Selecting the site of £uorescent protein attachment deserved
particular consideration. In the case of annexin 2, CFP was
fused to the C-terminal end since a correctly acetylated
Fig. 1. Intracellular localization of annexin 2-CFP and YFP-
S100A10 in living HepG2 cells. HepG2 cells were transfected with
expression constructs encoding annexin 2-CFP (A) or YFP-S100A10
(B). Cells expressing annexin 2-CFP show plasma membrane and
cytosolic staining, while the nucleus is devoid of label (A). S100A10
expression results in a di¡use cytosolic and nuclear £uorescence (B).
Arrows indicate plasma membrane staining. Scale bar: 10 Wm.
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N-terminal sequence has been shown to be required for e⁄-
cient S100A10 binding in in vitro studies [6,7]. On the other
hand, YFP was fused N-terminally to S100A10 since previous
biochemical studies had identi¢ed residues in the C-terminal
extension of S100A10 as being of crucial importance for an-
nexin 2 binding [8].
Annexin 2-CFP assumes a general cytoplasmic distribution
in transfected HepG2 cells (Fig. 1A). In addition, peripheral
staining at the plasma membrane is observed. This distribu-
tion is reminiscent of what has been observed for endogenous
annexin 2 in a number of cultured albeit ¢xed cells (for review
see [2]) indicating that the CFP tag does not interfere with the
binding of annexin 2 to its target membrane. As discussed
before (for review see [2]) it appears likely that the cytosolic
plus membrane distribution re£ects the dynamic nature of the
annexin 2-membrane interaction. Membrane binding of an-
nexin 2 is both reversible and regulated, e.g. by Ca2 and
membrane cholesterol content [23], and the protein most
likely shuttles between membrane and cytosol in a manner
modulated by changes in intracellular Ca2 concentration
and membrane and/or cell cortex composition.
In contrast to annexin 2-GFP the ectopically expressed
YFP-S100A10 protein shows a cytosolic and nuclear distribu-
tion with no enrichment at the plasma membrane (Fig. 1B).
Such non-structured appearance is in line with what has been
observed in non-di¡erentiated mouse F9 cells. These cells do
not express annexin 2 and the endogenous S100A10 is a cy-
tosolic protein in the absence of annexin 2 [20,24]. However,
this di¡ers from the situation in adrenergic chroma⁄n cells
where S100A10 is restricted to the subplasmalemmal region.
Here the protein has been proposed to serve as a docking
ligand for annexin 2 which translocates to this plasma mem-
brane region upon nicotine stimulation [15]. Thus while the
scenario might di¡er in certain secretory cells it appears to be
the general rule that annexin 2 is a partly membrane-associ-
ated protein in the absence of S100A10 whereas the S100A10
protein is only found in the cytosol when no annexin 2 is
present.
3.2. Annexin 2 can recruit S100A10 to the subplasmalemmal
region of HepG2 cells
The experiments so far had been carried out with singly
transfected HepG2 cells expressing either annexin 2 or
S100A10. We next analyzed whether co-expression of both
subunits of the complex can a¡ect their subcellular localiza-
tion. Therefore HepG2 cells were co-transfected with the an-
nexin 2-CFP and YFP-S100A10 expression plasmids and the
ability of the fusion proteins to form complexes with one
another was ¢rst analyzed biochemically. Lysates of HepG2
cells transiently expressing the two fusion proteins (transfec-
tion rate approx. 50%) were subjected to immunoprecipitation
using either annexin 2- or S100A10-speci¢c antibodies. Immu-
noblot analyses of the immunoprecipitates using antibodies
directed against either annexin 2 (not shown) or CFP/YFP
reveal cross-precipitation indicating that complex formation
had occurred (Fig. 2). All immunoprecipitations contained
only sub-stoichiometric amounts of the subunit that was not
directly bound by the antibody. Most likely this is due to the
fact that the epitopes of the monoclonal antibodies used for
immunoprecipitation partially overlap with the sites of com-
plex formation (C. Thiel, E. Kube and V. Gerke, unpublished
observation).
Given that the annexin 2-CFP and YFP-S100A10 fusion
proteins are capable of forming complexes with one another
we next monitored their intracellular localization by recording
the £uorescence protein signals in co-transfected cells. Fig. 3A
reveals that the distribution of annexin 2-CFP is indistinguish-
able of that observed in singly transfected cells. This shows
that the intracellular membrane localization of annexin 2
is not signi¢cantly a¡ected by formation of the annexin
2^S100A10 complex although a tight anchoring of annexin
2 in the cortical cytoskeleton appears to depend on complex
formation [17]. However, in the case of YFP-S100A10 co-ex-
Fig. 2. Immunoprecipitation of annexin 2-CFP and YFP-S100A10
from HepG2 cell lysates. Cells were co-transfected with annexin
2-CFP and YFP-S100A10. Lysates from the transfected cells were
subjected to immunoprecipitation with the monoclonal antibody
H21 directed against S100A10 (lane 1) or with the monoclonal anti-
body H28 directed against annexin 2 (lane 2). Immunoblotting of
the precipitates using polyclonal antibodies recognizing all GFP var-
iants reveals the co-precipitation of both fusion proteins at 70 kDa
(annexin 2-CFP) and at 35 kDa (YFP-S100A10).
Fig. 3. Intracellular distribution of annexin 2-CFP and S100A10 in
co-transfected live HepG2 cells. Cells were co-transfected with an-
nexin 2-CFP (A) and YFP-S100A10 (B) and the intracellular distri-
bution of both fusion proteins was analyzed 24 h following transfec-
tion. Note that both proteins co-localize at the plasma membrane in
the co-transfected cells (arrows). Scale bar: 10 Wm.
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pression with annexin 2-CFP results in an altered intracellular
distribution when compared to cells expressing YFP-S100A10
alone. The S100A10 fusion protein now localizes to both the
cytoplasm and the plasma membrane thus showing a distri-
bution overlapping with that of annexin 2-CFP (Fig. 3B). This
indicates that in HepG2 cells complex formation between ec-
topically expressed annexin 2 and S100A10 leads to a recruit-
ment of cytosolic S100A10 to the plasma membrane and that
this localization is mediated through the annexin 2 subunit of
the complex. Again this recruitment appears to di¡er from the
scenario in adrenergic chroma⁄n cells where annexin 2 is
translocated to the membrane only following cell stimulation
and where S100A10 appears to represent the main membrane
anchorage site [15]. Thus, di¡erent cells seem to regulate
membrane attachment of the annexin 2^S100A10 complex in
di¡erent ways with the mechanism described here for HepG2,
i.e. membrane recruitment mediated through the membrane
binding annexin 2 subunit, most likely representing the more
general one.
3.3. Conclusions
By employing ectopic expression of £uorescent protein-
tagged annexin 2 and S100A10 we could show that the two
proteins assume di¡erent subcellular localizations when ex-
pressed individually. Complex formation obtained in co-trans-
fected cells triggers a membrane recruitment of S100A10
which, in the absence of annexin 2, is solely cytosolic. Most
likely, this membrane recruitment is mediated through a direct
and Ca2 regulated interaction of the annexin 2 subunit of the
complex with membrane phospholipids. However, given the
enrichment of annexin 2 at sites of high membrane cholesterol
and/or F-actin attachment to membranes [18,19,23] other
modes of interaction of annexin 2 with the membrane and/
or cortical cytoskeleton possibly come into play as well. Once
anchored in the plasmalemmal region the molecular architec-
ture and multivalent properties of the annexin 2^S100A10
complex make it an attractive candidate for organizing in
conjunction with the cortical cytoskeleton membrane domains
and/or vesicular tra⁄c in the cell cortex.
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